<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/798EAC3E-AEA6-45D5-B418-7FBCC0257087"><gtr:id>798EAC3E-AEA6-45D5-B418-7FBCC0257087</gtr:id><gtr:firstName>Nicola</gtr:firstName><gtr:surname>Gray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127692697"><gtr:id>507E9C84-7DA5-463B-9947-029F5A77A130</gtr:id><gtr:title>Cytoplasmic regulation of mRNAs in reproductive biology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127692697</gtr:grantReference><gtr:abstractText>Genes must be regulated to ensure that they are expressed at the right time and place and in the correct amounts. Failure in this process can lead to disease. Genes can be regulated at multiple steps including at the level of mRNA translation. Work in recent years has revealed that the mis-regulation of mRNA translation is important in the aetiology of a wide range of human diseases including reproductive, neurological and metabolic disorders. Our work examines how mRNAs are regulated at the level of translation and the consequences of their mis-regulation. Current projects in the laboratory focus on specific translational control events during gametogenesis and early development which are important for fertility.</gtr:abstractText><gtr:technicalSummary>Genes must be regulated to ensure that they are expressed at the right time and place and in the correct amounts. Failure in this process can lead to disease. Work in recent years has revealed that the mis-regulation of mRNA translation is important in the aetiology of a wide range of human diseases including reproductive, neurological and metabolic disorders. Our research focuses on the role of mRNA translation during gametogenesis and early development when transcription is often quiescent, meaning that the required changes in the patterns of protein synthesis can only be achieved by the activation, repression or destruction of pre-existing mRNAs. In particular our lab is interested in the identification of novel regulators of translation, elucidating the molecular mechanisms of the mRNA specific regulators which have been identified and elucidating the physiological roles of these RNA/protein complexes in the normal and diseased state. Much of our current work focuses on two families of RNA-binding proteins that interact. These RNA-binding proteins have critical roles in gametogenesis and in the early development and as such our current work is relevant to the understanding of human infertility and fetal development. However, given the fundamental nature of our research, our work has to potential to provide insight into a wide variety of clinically relevant areas of biology. We address these questions using animal models (Xenopus), cell-culture and a wide variety of molecular and biochemical techniques as appropriate.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1317490</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>Tex-19</gtr:description><gtr:id>1C326B99-B97A-4069-9E8E-3323FC4346DF</gtr:id><gtr:impact>18802469</gtr:impact><gtr:outcomeId>7C165D1F3E8-1</gtr:outcomeId><gtr:partnerContribution>This has opened up a potential new area that may be subject to a grant application depending on preliminary data</gtr:partnerContribution><gtr:piContribution>We were involved in the basic functional analysis of Tex-19 which was knocked-out in mice.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>ePABP phosphorylation</gtr:description><gtr:id>849F2469-E262-4F1D-8292-5B942B4BF178</gtr:id><gtr:impact>Paper accepted for publication</gtr:impact><gtr:outcomeId>LeEjRvUmJHd-1</gtr:outcomeId><gtr:partnerContribution>Allowed us to understand the roles of phosphorylations that we had identified</gtr:partnerContribution><gtr:piContribution>Both teams contributed different aspects of reserach to provide a whole picture</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Biomedical and Life Sciences</gtr:department><gtr:description>PABP localisation</gtr:description><gtr:id>F09E2105-C039-4187-A928-656C7D67264E</gtr:id><gtr:impact>Work published</gtr:impact><gtr:outcomeId>KskLkLjDDbf-1</gtr:outcomeId><gtr:partnerContribution>We have been able to understand how are protein is moved in respeonse to cell stress a paper is in preparation</gtr:partnerContribution><gtr:piContribution>We have directed the majority of this research but benifited from the knowledge of our collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>SUA levels and renal failure</gtr:description><gtr:id>AAF6AA46-7475-47A3-A250-D9F9B3E21409</gtr:id><gtr:impact>19926891</gtr:impact><gtr:outcomeId>A80CF55E518-1</gtr:outcomeId><gtr:partnerContribution>This project made us explore immunofluroesence in oocytes and has resulted in a technique which we can now use to answer other questions.</gtr:partnerContribution><gtr:piContribution>We utilised an assay which we developed for a previous publication and established a new assay within th elab, this allowed us to identifying the fucntional effect of a mutation which causes renal failure</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>Tex-19</gtr:description><gtr:id>A41E8FA0-F060-488D-A56A-F5688A5F5E9A</gtr:id><gtr:impact>18802469</gtr:impact><gtr:outcomeId>76D90AFDF0D-1</gtr:outcomeId><gtr:partnerContribution>This has opened a potential new area of research which maybe the subject of a collaborative grant</gtr:partnerContribution><gtr:piContribution>We explored the putative function of Tex19, which was knocked-out in mice as part of the study</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>HSV-1</gtr:description><gtr:id>05AD9B73-930B-46A2-AC87-FDD3AC778B59</gtr:id><gtr:impact>We have contributed to three primary papers, one of which is submitted, two of which are in submission. We have also co-authored a review (18631144)</gtr:impact><gtr:outcomeId>EE9CCEFF744-1</gtr:outcomeId><gtr:partnerContribution>A post-doc was in my lab on secondment</gtr:partnerContribution><gtr:piContribution>We have contributed to three primary papers, one of which is submitted, two of which are in submission. We have also co-authored a review</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Biomedical and Life Sciences</gtr:department><gtr:description>HSV-1</gtr:description><gtr:id>9AB49618-B598-4772-8F6B-099F737782C6</gtr:id><gtr:impact>20573819
18631144
Another submitted publication under revision</gtr:impact><gtr:outcomeId>LdSts6osBGM-1</gtr:outcomeId><gtr:partnerContribution>Resulted in publications and project grant applications</gtr:partnerContribution><gtr:piContribution>We have directed the majority of research but have benifited from the facilities and knowledge of our collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wisconsin-Madison</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>PABP phenotypes</gtr:description><gtr:id>5215F25E-C941-42BE-AF34-3AA967AA0569</gtr:id><gtr:impact>Work published</gtr:impact><gtr:outcomeId>mBdcRT6bw86-1</gtr:outcomeId><gtr:partnerContribution>Allowed experiments to be performed that were not easily within our technical expertise</gtr:partnerContribution><gtr:piContribution>We have provided the majority of the work on understanding the phenotypes caused by PABP loss of function</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>SLC2A9 and renal failure</gtr:description><gtr:id>D294FF44-45FC-41A9-AE7B-68DD158EF738</gtr:id><gtr:impact>19926891</gtr:impact><gtr:outcomeId>3B2B867BEB7-1</gtr:outcomeId><gtr:partnerContribution>Allowed us to develop an immunofluroescence assay in oocytes that we have used to ask questions subsequently</gtr:partnerContribution><gtr:piContribution>We utilised an assay we previously established within the lan and established an additional assay. This allowed us to show the causative nature of mutations in SLC2A9 in some cases of renal failure.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>HSV-1 translation</gtr:description><gtr:id>7936D090-26AC-48F3-B102-60878E44FCAB</gtr:id><gtr:impact>Several papers publiches, One grant awarded by WT, one awarded by BBSRC</gtr:impact><gtr:outcomeId>C6DEA5E023B-1</gtr:outcomeId><gtr:partnerContribution>A post-doctoral worker was seconded to my lab.</gtr:partnerContribution><gtr:piContribution>We have contributed to three papers which are submitted or in preparation. One of these was almost entirely from our laboratory. Some reviews on this topic have also been written.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>SLC2A9</gtr:description><gtr:id>E6808B14-D064-4784-A438-299DFE835FB9</gtr:id><gtr:impact>19926891
Second paper in process of submission</gtr:impact><gtr:outcomeId>dY78kWdery2-1</gtr:outcomeId><gtr:partnerContribution>Publications and methodology development</gtr:partnerContribution><gtr:piContribution>Undertaking assays in oocytes to determine the functional impact of newly identified human mutations</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Keynote translation 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8FAFE485-9BA3-4A72-839A-9CF58AD22318</gtr:id><gtr:impact>Keynote talk</gtr:impact><gtr:outcomeId>56ddf87a4c82f4.33106220</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>123FD404-A8B3-4983-A150-8CB7EA6061F9</gtr:id><gtr:impact>MRC stand at science festival, designed by units and manned by students and post-docs. In some years I have been dorectly involved in stand design in terms of scientific message.

Unaware</gtr:impact><gtr:outcomeId>CzXwFA8PYH9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV appearance (BBC Scotland)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1AC22E51-B5C0-44FF-B131-D69933D79D21</gtr:id><gtr:impact>No measurable feedback was intreview to explain the results of research in response to press release

No measurable feedback</gtr:impact><gtr:outcomeId>JzKHx8e7P6K</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science festival</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA61F8F1-088D-4D79-A914-C97B8C2B44FC</gtr:id><gtr:impact>Post-doc on my Senior manned the exhibit at the Edinburgh Science Festival.

Difficult to ascertain the long term impact</gtr:impact><gtr:outcomeId>CD8E4E6DD76</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant/Biochemical Society</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>0E6D3DBB-5947-402B-B1C3-9D2CD1D5D6EB</gtr:id><gtr:outcomeId>sgQ3CNtf3rd0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1868414</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Program grant</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A640E32F-D9F9-4FF5-A10B-738FD1D59733</gtr:id><gtr:outcomeId>J9jmhUDtbz40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant/British Society of cell biology</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>British Society for Cell Biology (BSCB)</gtr:fundingOrg><gtr:id>A8FB23F1-E72E-4FD0-BDBC-1C8E66C4C0EE</gtr:id><gtr:outcomeId>ChAohtkhPTr0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant/Biochemical Society</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>47593D70-14B7-47A8-AA0F-74680686463A</gtr:id><gtr:outcomeId>ZDV33W2VFKj0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council IMPC</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P02419X/1</gtr:fundingRef><gtr:id>1536AAB6-FD52-4AC5-BF50-0C2BFF0E4BD3</gtr:id><gtr:outcomeId>58c849a87ba3e9.18700021</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>657064</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant PABP5</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J01687X/1</gtr:fundingRef><gtr:id>CEECD2DF-D397-43A1-9516-CA7FCC502748</gtr:id><gtr:outcomeId>HtqkE5dxGRe</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC repsonsive mode</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P022065/1</gtr:fundingRef><gtr:id>1870DC3C-80C4-424B-A2AD-51D12C9D9BEC</gtr:id><gtr:outcomeId>58c84b640e20a1.41677424</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant/society for experimental biology</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Society for Experimental Biology (SEB)</gtr:fundingOrg><gtr:id>39D0BE9D-88BE-40A4-9FBC-E888F9B4D673</gtr:id><gtr:outcomeId>iae67Mngku10</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225871</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Translational control by the multi-functional Herpes Simplex Virus Type I protein, ICP27)</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>464C25BC-CD46-4127-AF53-9F9CF86BE9C0</gtr:id><gtr:outcomeId>E1CDA337E1A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>293130</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>C830B8E6-EEB1-4355-902A-5579537D7E0E</gtr:id><gtr:outcomeId>pRTvQi9ykrL0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>757E4FDB-76EA-465E-A991-5165461A8B51</gtr:id><gtr:outcomeId>p6VW7haZGF7</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Travel awards</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E6E7D074-ED24-4776-AD5F-4D50F2D1654A</gtr:id><gtr:outcomeId>Dp5pVUKqsyu</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7A821193-DE49-4306-87D8-11EDD87E9C37</gtr:id><gtr:outcomeId>Yes1qvuX6p4</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B525CE5C-3E10-4460-8D29-4A2B5297CC33</gtr:id><gtr:outcomeId>SF7MQYtTuLu</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0DCE2DD1-43DC-4C85-AB7D-5EA062279EE9</gtr:id><gtr:outcomeId>U9tVa1KSTew</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Antibodies being licenced to commerical company</gtr:description><gtr:id>1C7862CB-C980-478B-A82F-29EED921E398</gtr:id><gtr:impact>To early to determine</gtr:impact><gtr:outcomeId>qPghHcS66zf</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>PABP specific antibodies</gtr:title><gtr:type>Products with applications outside of medicine</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Have been asked to provide several antibodies commercially, discussions ongoing.</gtr:description><gtr:id>FCC3C8D7-1DB4-41C9-974D-CA5DFF64F5DA</gtr:id><gtr:impact>N/A - not yet in market</gtr:impact><gtr:outcomeId>JBHaHCQFu5r</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Antibodies</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A series of unique antibodies have been generated against individual members of the PABP family</gtr:description><gtr:id>FAFC35FA-1532-4288-B338-21645EF097B9</gtr:id><gtr:impact>Allowed studies not previously possibe.</gtr:impact><gtr:outcomeId>rHdxaM4amFn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PABP-specific antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A facility to permit research using Xenopus, a non-mammlain vertebrate model was established.</gtr:description><gtr:id>C97AA1D7-5302-476E-A52E-7BAD130C9D2C</gtr:id><gtr:impact>In addition to our own publications, this facility provides facilitates research for other Edinburgh University Xenopus users enabling their research and fostering a collaborative environment. Collaboration also allows for 3Rs- by reduction (i.e. material/animal can be shared between multiple groups)</gtr:impact><gtr:outcomeId>305B35ED627</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New Xenoups facility</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibody raised against Xenopus protein</gtr:description><gtr:id>EDAAAFC9-579B-4D2B-AD15-A2E507FCBABC</gtr:id><gtr:impact>Enabled stuides of expression and protein-protein interactions</gtr:impact><gtr:outcomeId>XCgcyFPrYt7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DAZAP antibody</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7041340E-E90C-4CDB-8246-6C7E22C41AE4</gtr:id><gtr:title>Viral and cellular mRNA-specific activators harness PABP and eIF4G to promote translation initiation downstream of cap binding.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b9f4b8811e11377496d7cde42c11c99"><gtr:id>5b9f4b8811e11377496d7cde42c11c99</gtr:id><gtr:otherNames>Smith RWP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a2fcc31788440.17629253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0694B9C9-3F98-4DAE-B56B-6E36B9CF102B</gtr:id><gtr:title>Cytoplasmic mRNA: move it, use it or lose it!</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3411d1d6db9c604f26f1a8b5f65d4e42"><gtr:id>3411d1d6db9c604f26f1a8b5f65d4e42</gtr:id><gtr:otherNames>Coldwell MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>J5zdFLyax1t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2535FF9F-E5FE-45D3-A9E8-67C9B058181A</gtr:id><gtr:title>A tail of translational regulation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af020d126456d05e975c5e00c444d0ae"><gtr:id>af020d126456d05e975c5e00c444d0ae</gtr:id><gtr:otherNames>Gray GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5aa7f7f186f312.58293787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94AC0F38-FD81-478D-AE58-815540926649</gtr:id><gtr:title>Poly(A)-binding proteins are functionally distinct and have essential roles during vertebrate development.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6c3d99a3715c5e41866fdf6c5c82f2e"><gtr:id>d6c3d99a3715c5e41866fdf6c5c82f2e</gtr:id><gtr:otherNames>Gorgoni B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Kr6viDbRcw4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEAB99F3-0486-4878-A7CD-99A2B4A40D34</gtr:id><gtr:title>FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/987e9e3fb4f64dcfba76b83df99acc5a"><gtr:id>987e9e3fb4f64dcfba76b83df99acc5a</gtr:id><gtr:otherNames>Rosario R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c848838e2ff7.17585625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66ABC3D8-EEA7-4968-BAD3-2E90009649D0</gtr:id><gtr:title>An integrated model for the nucleo-cytoplasmic transport of cytoplasmic poly(A)-binding proteins.</gtr:title><gtr:parentPublicationTitle>Communicative &amp; integrative biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3912a364780c8182e227f9fce6eacc"><gtr:id>4e3912a364780c8182e227f9fce6eacc</gtr:id><gtr:otherNames>Burgess HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1942-0889</gtr:issn><gtr:outcomeId>pm_13491_21_22896784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48E79CDF-CFEB-400C-B2B6-7D702E66FB04</gtr:id><gtr:title>Embryonic poly(A)-binding protein (ePAB) phosphorylation is required for Xenopus oocyte maturation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fe8c1d4897aa3340d17438a801f8bf1"><gtr:id>4fe8c1d4897aa3340d17438a801f8bf1</gtr:id><gtr:otherNames>Friend K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13491_21_22497250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F09313F-0B6B-4B09-A34F-24F60CCFA979</gtr:id><gtr:title>DAZAP1, an RNA-binding protein required for development and spermatogenesis, can regulate mRNA translation.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61c9b01397073965ad36d2de1b9f9e36"><gtr:id>61c9b01397073965ad36d2de1b9f9e36</gtr:id><gtr:otherNames>Smith RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>jyVEZub9ViE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC05927E-A4D4-4315-88B4-5DDF6583B1D6</gtr:id><gtr:title>mRNA-specific regulation of translation by poly(A)-binding proteins.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3912a364780c8182e227f9fce6eacc"><gtr:id>4e3912a364780c8182e227f9fce6eacc</gtr:id><gtr:otherNames>Burgess HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>YWVrqkLKTDf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B8E2F5D-6443-42F9-A7BA-51FC3A365490</gtr:id><gtr:title>The DAZL and PABP families: RNA-binding proteins with interrelated roles in translational control in oocytes.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>D13D85AFFE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC05097C-8C3E-4867-ACF2-4E3BC8B2A314</gtr:id><gtr:title>Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89efa5c9a7c298f5d863d87435f42d23"><gtr:id>89efa5c9a7c298f5d863d87435f42d23</gtr:id><gtr:otherNames>Dinour D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>pm_13491_21_21810765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50A26412-8A84-40D8-AA87-E2BEDDC5A6AF</gtr:id><gtr:title>The multifunctional poly(A)-binding protein (PABP) 1 is subject to extensive dynamic post-translational modification, which molecular modelling suggests plays an important role in co-ordinating its activities.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>544f74634be630.39644736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D61AACD6-58AD-49CF-8F4F-B8CC13ED3EF4</gtr:id><gtr:title>Nuclear relocalisation of cytoplasmic poly(A)-binding proteins PABP1 and PABP4 in response to UV irradiation reveals mRNA-dependent export of metazoan PABPs.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3912a364780c8182e227f9fce6eacc"><gtr:id>4e3912a364780c8182e227f9fce6eacc</gtr:id><gtr:otherNames>Burgess HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_13491_21_21940797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DBCB671-608A-4839-ADFA-CA88D437B3C1</gtr:id><gtr:title>Poly(A)-binding protein 1 partially relocalizes to the nucleus during herpes simplex virus type 1 infection in an ICP27-independent manner and does not inhibit virus replication.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fac44f1cb00caf8383617ca35446fe5e"><gtr:id>fac44f1cb00caf8383617ca35446fe5e</gtr:id><gtr:otherNames>Salaun C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>keHptQgPMGx</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127692697</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>